Advertisement
Australia markets open in 5 hours 46 minutes
  • ALL ORDS

    8,002.80
    -20.10 (-0.25%)
     
  • AUD/USD

    0.6646
    -0.0006 (-0.09%)
     
  • ASX 200

    7,759.60
    -23.40 (-0.30%)
     
  • OIL

    81.56
    +0.66 (+0.82%)
     
  • GOLD

    2,335.40
    +22.20 (+0.96%)
     
  • Bitcoin AUD

    92,976.72
    +1,174.84 (+1.28%)
     
  • CMC Crypto 200

    1,287.74
    +21.60 (+1.71%)
     

Sarepta Stock Surges on Expanded Elevidys Approval. It’s a ‘Best-Case’ Scenario for Shares.

Sarepta Stock Surges on Expanded Elevidys Approval. It’s a ‘Best-Case’ Scenario for Shares.

The biopharmaceutical company says the drug was approved for ambulatory and non-ambulatory people, who are at least 4 years old, and with a confirmed mutation in the DMD gene.